Modafinil for the treatment of cancer-related fatigue: An intervention study;Modafinil zur Behandlung der Tumorfatigue: Eine Interventionsstudie

Schmerz

Volumn 24, Issue 6, 2010, Pages 587-595

  Wirz, S ^a   Nadstawek, J ^b   Kuhn K U ^c   Vater, S ^b   Junker, U ^d   Wartenberg, H C ^e  

^a CURA Katholisches Krankenhaus im Siebengebirge   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Fatigue; Modafinil; Opioids; Pain

Indexed keywords

MODAFINIL; OPIATE;

ALERTNESS; ARTICLE; CANCER FATIGUE; CLINICAL ARTICLE; COGNITION; EPWORTH SLEEPINESS SCALE; HUMAN; PATIENT ASSESSMENT; PATIENT SATISFACTION; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; PERSONALITY ASSESSMENT; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 78651390518     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-010-0987-y     Document Type: Article

References (44)

1. Blackhall L, Petroni G, Shu J et al (2009) A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 12(5):433-439
2. Brickenkamp R (2002) Allgemeine Leistungstests, 9. Aufl. Hogrefe, Göttingen
3. Brown JN, Howard CA, Kemp DW (2010) Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 44(6):1098-1103
4. Bruera E, Driver L, Barnes EA et al (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 1;21(23):4439-4443
5. Bruera E, Valero V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 1;24(13):2073-2078
6. Carroll JK, Kohli S, Mustian KM et al (2007) Pharmacologic treatment of cancer-related fatigue. Oncologist 12:43-51
7. Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACTAn) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34:13-19
8. Cella D, Peterman A, Passik S et al (1998) Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12(11A):369-377
9. Cella D, Davis K, Breitbart W et al (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385-3391
10. Cooper MR, Bird HM, Steinberg M (2009) Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann Pharmacother 43(4):721-725
11. Curt GA, Breitbart W, Cella D (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5(5):353-360
12. Fleishman S, Lower E, Zeldis J et al (2005) A phase II, randomized, placebo-controlled trial of the safety and efficacy of dexmethylphenidate (d-MPH) as a treatment for fatigue and chemobrain in adult cancer patients. Breast Cancer Res Treat 94:S214
13. Gallopin T, Luppi PH, Rambert FA et al (2004) Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 27(1):19-25
14. Given CW, Given B, Azzouz F et al (2001) Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 21:456-466 (Pubitemid 32492931)
15. Glaus A (1998) Fatigue in patients with cancer - analysis and assessment. Recent Results Cancer Res 145:54-76
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
17. Hann DM, Jacobsen PB, Azzarello LM et al (1998) Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 7(4):301-310
18. Jacobsen PB, Donovan KA, Weitzner MA (2003) Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 8:229-240
19. Jean-Pierre P, Figueroa-Moseley CD, Kohli S et al (2007) Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12(Suppl 1):11-21
20. Jean-Pierre P, Morrow GR, Roscoe JA et al (2010) A phase 3 randomized, placebo-controlled, double- blind, clinical trial of the effect of modafinil on can- cer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Re- search base study. Cancer 15;116(14):3513-3520
21. Johns MW (1991) A new method of measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540-545
22. Kim SH, Son BH, Hwang SY et al (2008) Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quali- ty of life. J Pain Symptom Manage 35(6):644-655
23. Kohli S, Fisher SG, Tra Y (2009) The effect of moda- finil on cognitive function in breast cancer survi- vors. Cancer 15;115(12):2605-2616
24. Krupp LB, LaRocca NG, Muir-Nash J et al (1989) The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythemato- sus. Arch Neurol 46:1121-1123
25. Lawrence DP, Kupelnick B, Miller K (2004) Evidence report on the occurrence, assessment, and treat- ment of fatigue in cancer patients. J Natl Cancer Inst Monogr (32):40-50
26. Minton O, Richardson A, Sharpe M et al (2008) A systematic review and meta-analysis of the phar- macological treatment of cancer-related fatigue. J Natl Cancer Inst 100:1155-1166
27. Minton O, Richardson A, Sharpe M et al (2010) Drug therapy for the management of cancer-re- lated fatigue. Cochrane Database Syst Rev 7;7: CD006704
28. Moraska AR, Sood A, Dakhil SR et al (2010) Pha- se III, randomized, double-blind, placebo-control- led study of long-acting methylphenidate for can- cer-related fatigue: North Central Cancer Treat- ment Group NCCTG-N05C7 Trial. J Clin Oncol 10;28(23):3673-3679
29. Morrow GR, Shelke AR, Roscoe JA (2005) Manage- ment of cancer-related fatigue. Cancer Invest 23(3):229-239
30. National Comprehensive Cancer Network (2006) Cancer-related fatigue panel 2006 guidelines. ht- tp://www.nccn.or1982 g/professionals/physician- gls/f-guidelines.asp
31. Oken MM, Creech RH, Tormey DC et al (1982) To- xicity and response criteria of the Eastern Coope- rative Oncology Group. Am J Clin Oncol 5(6):649-655
32. Radbruch L, Sabatowski R, Elsner F et al (2003) Va- lidation of the German version of the brief fatigue inventory. J Pain Symptom Manage 25(5):449-458
33. Radbruch L, Strasser F, Elsner F et al (2008) Re- search Steering Committee of the European Asso- ciation for Palliative Care (EAPC). Fatigue in pallia- tive care patients - an EAPC approach. Palliat Med 22(1):13-32
34. Ryan JL, Carroll JK, Ryan EP et al (2007) Mechanis- ms of cancer-related fatigue. Oncologist 12(Suppl 1):22-34
35. Sarhill N, Walsh D, Nelson KA (2001) Methylphe- nidate for fatigue in advanced cancer: a prospec- tive open-label pilot study. Am J Hosp Palliat Care 18(3):187-192
36. Sharpe M, Strong V, Allen K (2004) Major depres- sion in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 26;90(2):314-320
37. Sinnott C (2002) Problems recruiting cancer pa- tients to a comparative clinical trial of drug treat- ments for neuropathic pain in palliative care. J Pain Symptom Manage 23(4):270-272
38. Spathis A, Dhillan R, Booden D (2009) Modafinil for the treatment of fatigue in lung cancer: a pilot stu- dy. Palliat Med 23(4):325-331
39. Stone P, Hardy J, Broadley K et al (1999) Fatigue in advanced cancer: a prospective controlled cross- sectional study. Br J Cancer 79:1479-1486
40. Stone P, Richards M, AHern R et al (2000) A stu- dy to investigate the prevalence, severity and cor- relates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11:561-567
41. Vaishnavi S, Gadde K, Alamy S (2006) Modafinil for atypical depression: effects of open-label and dou- ble-blind discontinuation treatment. J Clin Psycho- pharmacol 26:373-378
42. Vogelzang NJ, Breitbart W, Cella D (1997) Patient, caregiver, and oncologist perceptions of cancer-re- lated fatigue: results of a tripart assessment sur- vey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4-12
43. Webster L, Andrews M, Stoddard G (2003) Moda- finil treatment of opioid-induced sedation. Pain Med 4(2):135-140
44. Zifko UA, Rupp M, Schwarz S (2002) Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 249(8):983-987